Cevimeline Hydrochloride Capsule
Product Images NDC 72888-118

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 72888-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-00, Bottle of 1000 Label)

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-00, Bottle of 1000 Label)
Label of Cevimeline Hydrochloride Capsules 30 mg by Advagen Pharma Ltd. The label states each capsule contains 30 mg cevimeline hydrochloride. It includes storage instructions, container dispensing advice, and warnings to keep out of reach of children. The product is manufactured by Rubicon Research Private Limited, India. The package contains 1000 capsules for prescription use only.*
FDA Label Image

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-01, Bottle of 100 Label)

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-01, Bottle of 100 Label)
Label for Cevimeline Hydrochloride Capsules 30 mg by Advagen Pharma Ltd. The label indicates each capsule contains 30 mg cevimeline hydrochloride, with a package size of 100 capsules. The label includes storage instructions and distributor and manufacturer information: Advagen Pharma Limited, Plainsboro, NJ, and Rubicon Research Private Limited, India.*
FDA Label Image

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-30, Bottle of 30 Label)

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-30, Bottle of 30 Label)
Label for Cevimeline Hydrochloride Capsules 30 mg, containing 30 capsules. The label includes storage instructions (store at 20° to 25°C), a warning to keep medication out of reach of children, and dispensing guidelines. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The product is indicated as Rx only with NDC 72888-118-30.*
FDA Label Image

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-05, Bottle of 500 Label)

Cevimeline Hydrochloride Capsules 30mg (NDC 72888-118-05, Bottle of 500 Label)
Label for Cevimeline Hydrochloride Capsules 30 mg, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label states 500 capsules per container, for prescription use only. Storage instructions include keeping the product between 20° to 25°C with permitted excursions. The label features barcode and includes handling precautions.*
FDA Label Image

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1). Its Empirical Formula Is C10h17nos.hcl. (Cevimeline Hydrochloride Capsules Structure)

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1).  Its Empirical Formula Is C10h17nos.hcl. (Cevimeline Hydrochloride Capsules Structure)
Chemical structure of cevimeline hydrochloride monohydrate, showing the molecular arrangement including a thioether group, an oxygen atom in an ether linkage, a methyl side chain, and a bicyclic amine structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.